Volume 22, Number 6—June 2016
CME ACTIVITY - Synopsis
Infectious Disease Risk Associated with Contaminated Propofol Anesthesia, 1989–20141
Table 4
Followed manufacturers’ precautions, study, year | Type of study | Preservative-free propofol† | Other agents compared with propofol | Type of infection | Hospital unit‡ | Association§ |
---|---|---|---|---|---|---|
Yes | ||||||
Seeberger et al., 1998 | Retrospective cohort | Yes | Thiopentone | Sepsis | OR | No |
Shimizu et al., 2010 | Cohort | ND | Sevoflurane | SSI | OR | Yes |
Haddad et al., 2011 | Nested cohort | Yes | ND | Multiple¶ | ICU | Yes |
Moehring et al., 2014 |
Case–control |
ND |
Fentanyl |
BSI |
ICU |
No |
No | ||||||
Bennett et al., 1995. (2) | Case–control and cohort | Yes | Sufentanil, alfentanil | BSI, SSI | OR | Yes |
Henry et al., 2001 (4) | Case–control | Yes | ND | BSI, SSI | OR | Yes |
McNeil et al., 1999 | Cohort | Yes | Sufentanil, fentanyl, midazolam, vecuronium | Fungemia, endophthalmitis | OR | Yes |
Sebert et al., 2002. | Case–control | ND | ND | BSI | OR | No |
Muller et al., 2010 (15) |
Retrospective cohort |
ND |
Fentanyl, midazolam |
BSI, SIRS |
OR |
Yes |
ND | ||||||
Kontopoulou et al., 2012 |
Case–control |
ND |
ND |
BSI |
ICU |
Yes |
*Complete data and full references are available in the Technical Appendix; OR, operating room; ICU, intensive care unit; BSI, bloodstream infection; SSI, Surgical site infection; ND, not described in publication; SIRS, systemic inflammatory response syndrome. †Use of propofol without antimicrobial additives. ‡Hospital unit where the studies were conducted. §Conclusion of the analytical study regarding the association between propofol exposure and infectious events. ¶Multiple infection types, including ventilator-associated pneumonia, urosepsis, BSI, catheter-related infections, and others. |
1Part of this work was presented at the XXXI Colombian Congress of Anesthesiology and Critical Care, Cali, Columbia, July 2015.
Page created: May 11, 2016
Page updated: May 11, 2016
Page reviewed: May 11, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.